Proficiency of nerve conduction using standard methods and reference values (cl. NPhys Trial 4)

Muscle and Nerve

Volumn 50, Issue 6, 2014, Pages 900-908

  Litchy, William J ^a   Albers, James W ^b   Wolfe, James ^b   Bolton, Charles F ^c   Walsh, Nancy ^c   Klein, Christopher J ^a   Zafft, Andrew J ^a   Russell, James W ^d   Zwirlein, Melanie ^d   Overland, Carol J ^a   Davies, Jenny L ^a   Carter, Rickey E ^a   Dyck, Peter J ^a   James, P ^a   Dyck, B ^a   Low, Phillip A ^a   Andersen, Henning ^e   England, John D ^f   Llewelyn, Gareth ^g   Mauermann, Michelle L ^a   Singer, Wolfgang ^a   Selvarajah, Dinesh ^h   Tesfaye, Solomon ^h   Smith, Gordon A ⁱ   Vella, Adrian ^a   more..

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c QUEEN S UNIVERSITY   (Canada)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

^f LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^h ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

ⁱ UNIVERSITY OF UTAH   (United States)

Author keywords

Multicenter trial; Nerve conduction accuracy; Nerve conduction proficiency; Neuropathy impairment score; Reference values

Indexed keywords

AGED; CLINICAL TRIAL; COMPARATIVE STUDY; DIABETIC NEUROPATHIES; ELECTRODIAGNOSIS; HUMAN; INNERVATION; LEG; MULTICENTER STUDY; NERVE CONDUCTION; NEUROPHYSIOLOGY; OBSERVER VARIATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; REFERENCE VALUE; REPRODUCIBILITY; STANDARDS;

AGED; DIABETIC NEUROPATHIES; ELECTRODIAGNOSIS; HUMANS; LEG; NEURAL CONDUCTION; NEUROPHYSIOLOGY; OBSERVER VARIATION; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS;

EID: 84912102923     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.24243     Document Type: Article

References (17)

1. Dyck PJ, Albers JW, Wolfe J, Bolton CF, Walsh N, Klein CJ, et al. A trial of proficiency of nerve conduction: greater standardization still needed. Muscle Nerve 2013;48:369-374.
2. Chaudhry V, Cornblath DR, Mellitis ED, Avila O, Freimer ML, Glass JD, et al. Inter- and intra-examiner reliability of nerve conduction measurements in normal subjects. Ann Neurol 1991;30:841-843.
3. Kimura J. Nerve conduction and needle electromyograpy. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy, 4th ed. Vol. 1. Philadelphia: Elsevier; 2005. p 899-970.
4. Thompson PD, Thomas PK. Clinical patterns of peripheral neuropathy. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy, 4th ed. Philadelphia: Elsevier; 2005. p 1137-1162.
5. Schifitto G, Yiannoutsos C, Simpson DM, Adornato BT, Singer EJ, Hollander H, et al. Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathy. Neurology 2001;57:1313-1316.
6. Dyck PJ, O'Brien PC, Oviatt KF, Dinapoli RP, Daube JR, Bartleson JD, et al. Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol 1982;11:136-141.
7. Apfel SC, Schwartz S, Adornato BT, Freeman R, Biton V, Rendell M, et al. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy. A randomized controlled trial. JAMA 2000;284:2215-2221.
8. Ziegler D, Ametov A, Barinov A, Dyck PJ, Gurieva I, Low PA, et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care 2006;29:2365-2370.
9. Ziegler D, Low PA, Litchy WJ, Boulton AJ, Vinik AI, Freeman R, et al. Efficacy and safety of antioxidant treatment with alpha-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 Trial. Diabetes Care 2011;34:2054-2060.
10. Berk JL, Suhr OB, Obici L, Sekijima Y, Zeldenrust SR, Yamashita T, et al. Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial. JAMA 2013;310:2658-2667.
11. Smith BE, Windebank AJ, Dyck PJ. Nonmalignant inflammatory sensory polyganglionopathy. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy, 4th ed. Philadelphia: Elsevier Saunders; 2005. p 2309-2320.
12. Grant IA, Benstead TJ. Differential diagnosis of polyneuropathy. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy, 4th ed. Vol. 1. Philadelphia: Elsevier; 2005. p 1163-1180.
13. Suanprasert N, Berk JL, Benson MD, Dyck PJB, Klein CJ, Gollob JA, et al. Toward representative quantitation of neuropathy signs and tests in transthyretin amyloidosis. 2014 (in preparation).
14. Dyck PJ, Overland CJ, Low PA, Litchy WJ, Davies JL, Dyck PJB, et al. Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys Trial. Muscle Nerve 2010;42:157-164.
15. Dyck PJ, Litchy WJ, Lehman KA, Hokanson JL, Low PA, O'Brien PC. Variables influencing neuropathic endpoints: the Rochester Diabetic Neuropathy Study of healthy subjects (RDNS-HS). Neurology 1995;45:1115-1121.
16. Dyck PJ, Overland CJ, Low PA, Litchy WJ, Davies JL, Dyck PJB, et al. "Unequivocally abnormal" vs. "usual" signs and symptoms for proficient diagnosis of diabetic polyneuropathy Cl vs. N Phys Trial. Arch Neurol 2012;69:1609-1614.
17. Dyck PJ, Argyros B, Russell JW, Gahnstrom L, Naleppa S, Albers JW, et al. Multicenter trial of the proficiency of smart quantitative sensation tests. Muscle Nerve 2013 Aug 8. [Epub ahead of print]. PMID: 23929701. DOI:10.1002/mus.23982.